4//SEC Filing
CESCA THERAPEUTICS INC. 4
Accession 0001140361-17-020985
$THMOCIK 0000811212operating
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:04 PM ET
Size
5.5 KB
Accession
0001140361-17-020985
Insider Transaction Report
Form 4
Westgate Mark
Director
Transactions
- Award
Stock Options
2017-05-10$3.19/sh+13,500$43,065→ 13,500 totalExercise: $3.19Exp: 2027-05-10→ Common Stock (13,500 underlying)
Footnotes (1)
- [F1]The option vests as to 562 shares on the date of grant, 562 shares on the last day of each month thereafter for 22 months (beginning on June 30, 2017) and 574 shares on April 30, 2019, subject to the early termination provisions and other terms and conditions of the 2016 Equity Incentive Plan, as amended.
Documents
Issuer
CESCA THERAPEUTICS INC.
CIK 0000811212
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000811212
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:04 PM ET
- Size
- 5.5 KB